| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 941 | 2018 |
| Validation of the functional assessment of multiple sclerosis quality of life instrument DF Cella, K Dineen, B Arnason, A Reder, KA Webster, G Karabatsos, ... Neurology 47 (1), 129-139, 1996 | 592 | 1996 |
| Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing … E Havrdova, S Galetta, M Hutchinson, D Stefoski, D Bates, CH Polman, ... The Lancet Neurology 8 (3), 254-260, 2009 | 591 | 2009 |
| Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial R Gold, G Giovannoni, K Selmaj, E Havrdova, X Montalban, EW Radue, ... The Lancet 381 (9884), 2167-2175, 2013 | 336 | 2013 |
| Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation RK Burt, AE Traynor, R Pope, J Schroeder, B Cohen, KH Karlin, L Lobeck, ... Blood, The Journal of the American Society of Hematology 92 (10), 3505-3514, 1998 | 310 | 1998 |
| Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in … RK Burt, BA Cohen, E Russell, K Spero, A Joshi, Y Oyama, WJ Karpus, ... Blood 102 (7), 2373-2378, 2003 | 254 | 2003 |
| Orally administered 4‐aminopyridine improves clinical signs in multiple sclerosis FA Davis, D Stefoski, J Rush Annals of Neurology: Official Journal of the American Neurological …, 1990 | 223 | 1990 |
| 4‐Aminopyridine improves clinical signs in multiple sclerosis D Stefoski, FA Davis, M Faut, CL Schauf Annals of Neurology: Official Journal of the American Neurological …, 1987 | 188 | 1987 |
| Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used Y Loh, Y Oyama, L Statkute, K Quigley, K Yaung, E Gonda, W Barr, ... Blood 109 (6), 2643-2548, 2007 | 179 | 2007 |
| Freedom from disease activity in multiple sclerosis E Havrdova, S Galetta, D Stefoski, G Comi Neurology 74 (17_supplement_3), S3-S7, 2010 | 171 | 2010 |
| T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients RK Burt, AE Traynor, B Cohen, KH Karlin, FA Davis, D Stefoski, C Terry, ... Bone marrow transplantation 21 (6), 537-541, 1998 | 142 | 1998 |
| MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group CHAMPS Study Group* Neurology 59 (7), 998-1005, 2002 | 120 | 2002 |
| Methylation patterns of cell-free plasma DNA in relapsing–remitting multiple sclerosis T Liggett, A Melnikov, S Tilwalli, Q Yi, H Chen, C Replogle, X Feng, ... Journal of the neurological sciences 290 (1-2), 16-21, 2010 | 116 | 2010 |
| Meningiomas with conspicuous plasma cell‐lymphocytic components. A report of five cases BC Horten, H Urich, D Stefoski Cancer 43 (1), 258-264, 1979 | 115 | 1979 |
| 4‐Aminopyridine in multiple sclerosis: Prolonged administration D Stefoski, FA Davis, WE Fitzsimmons, SS Luskin, J Rush, GW Parkhurst Neurology 41 (9), 1344-1344, 1991 | 114 | 1991 |
| Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial G Giovannoni, R Gold, K Selmaj, E Havrdova, X Montalban, EW Radue, ... The Lancet Neurology 13 (5), 472-481, 2014 | 106 | 2014 |
| Hematopoietic stem cell transplantation for multiple sclerosis RK Burt, B Cohen, J Rose, F Petersen, Y Oyama, D Stefoski, ... Archives of neurology 62 (6), 860-864, 2005 | 97 | 2005 |
| Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis EW Radue, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ... Journal of the neurological sciences 292 (1-2), 28-35, 2010 | 84 | 2010 |
| Toward a treatment logic for sleep apnea: the place of the tongue retaining device R Cartwright, D Stefoski, D Caldarelli, H Kravitz, S Knight, S Lloyd, ... Behaviour research and therapy 26 (2), 121-126, 1988 | 78 | 1988 |
| Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum Y Guo, VA Lennon, BFG Popescu, CK Grouse, J Topel, M Milone, ... JAMA neurology 71 (8), 1025-1029, 2014 | 73 | 2014 |
